MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 155 filers reported holding MEDICINES CO in Q3 2014. The put-call ratio across all filers is 9.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,929,000 | +44.1% | 39,457 | 0.0% | 0.01% | +27.3% |
| Q4 2016 | $1,339,000 | -10.1% | 39,457 | 0.0% | 0.01% | -8.3% |
| Q3 2016 | $1,489,000 | +56.9% | 39,457 | +39.9% | 0.01% | +33.3% |
| Q2 2016 | $949,000 | +26.0% | 28,207 | +19.0% | 0.01% | +28.6% |
| Q1 2016 | $753,000 | -14.9% | 23,696 | 0.0% | 0.01% | -22.2% |
| Q4 2015 | $885,000 | -1.7% | 23,696 | 0.0% | 0.01% | -10.0% |
| Q3 2015 | $900,000 | +64.8% | 23,696 | +24.2% | 0.01% | +66.7% |
| Q2 2015 | $546,000 | +2.1% | 19,086 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $535,000 | +1.3% | 19,086 | 0.0% | 0.01% | -14.3% |
| Q4 2014 | $528,000 | +23.9% | 19,086 | 0.0% | 0.01% | +16.7% |
| Q3 2014 | $426,000 | -3.8% | 19,086 | +25.3% | 0.01% | 0.0% |
| Q2 2014 | $443,000 | +2.3% | 15,237 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $433,000 | -26.4% | 15,237 | 0.0% | 0.01% | -30.0% |
| Q4 2013 | $588,000 | +15.1% | 15,237 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $511,000 | +12.6% | 15,237 | +3.3% | 0.01% | +11.1% |
| Q2 2013 | $454,000 | – | 14,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |